amiodarone has been researched along with diltiazem in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (12.20) | 18.7374 |
1990's | 6 (7.32) | 18.2507 |
2000's | 41 (50.00) | 29.6817 |
2010's | 20 (24.39) | 24.3611 |
2020's | 5 (6.10) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Keserü, GM | 1 |
Cianchetta, G; Cruciani, G; Fravolini, A; Giesing, D; Singleton, RW; Vaz, RJ; Wildgoose, M; Zhang, M | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jia, L; Sun, H | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Broustet, JP; Douard, H; Mora, B | 1 |
Gonzalez-Sicilia, L; Hernandez, J; Laorden, ML; Perez, D; Villalobos, JP | 1 |
Gueron, M; Kracoff, OH; Ovsyshcher, I | 1 |
Schwartz, PJ; Vanoli, E | 1 |
Eloy, JP; Lesbre, JP | 1 |
Antman, EM; Friedman, PL; Goldman, L; Lee, TH; Stone, PH | 1 |
Hess, DS; Scheinman, MM | 1 |
Bertrand, ME; Lablanche, JM; Thieuleux, FA; Tilmant, PY | 1 |
Alegría, E; Arcas, R; Barba, J; Llorens, R; Malpartida, F; Martín Trenor, A | 1 |
Barnay, C; Hanvic, G; Medvedowsky, JL | 1 |
Decrinis, M; Kasper, K; Schulze-Bauer, C; Stark, G; Stark, U; Tritthart, HA | 2 |
Fledelius, HC; Thystrup, JD | 1 |
Bataller, M; Chorro, FJ; Cortina, J; Espí, J; Guerrero, J; López-Merino, V; Ruipérez, JA; Sánchez-Muñoz, JJ; Sanchis, J | 1 |
Steinbeck, G | 1 |
Hohnloser, SH; Kuck, KH | 2 |
Cleland, JG; Kaye, GC; Khand, AU; Rankin, AC | 1 |
Capucci, A; Piepoli, MF; Terracciano, C; Villani, GQ | 1 |
Hohnloser, SH; Kuck, KH; Lilienthal, J | 1 |
Landwojtowicz, E; Seelig, A | 1 |
Harrison, RA; Liratsopulos, G | 1 |
Hohnloser, SH | 1 |
Delle Karth, G; Geppert, A; Gschwandtner, M; Haumer, M; Heinz, G; Neunteufl, T; Priglinger, U; Siostrzonek, P | 1 |
Bruckman, D; Decena, BF; Eagle, KA; Kim, MH; McHale, C; Morady, F; Rachwal, W; Russman, P | 1 |
Cieśliński, A; Grajek, S; Grygier, M; Mularek-Kubzdela, T; Seniuk, W | 1 |
Kanorskiĭ, SG; Zingilevskiĭ, KB | 1 |
Curtis, AB; Saxonhouse, SJ | 1 |
Dermitzaki, DN; Kallergis, EM; Kambouraki, DC; Kanoupakis, EM; Manios, EG; Mavrakis, HE; Vardas, PE | 1 |
Nattel, S | 1 |
Kohno, Y; Suzuki, A; Yamamoto, T | 1 |
Bass, EB; Tamariz, LJ | 1 |
Freestone, B; Kamath, S; Lip, G | 1 |
Freestone, B; Lip, GY | 2 |
Holmes, EC; Samuels, FL; Samuels, LE | 1 |
Bougioukas, G; Didilis, V; Konstantinou, F; Mikroulis, D; Tsakiridis, K; Vretzakis, G | 1 |
Lip, GY | 1 |
Ampollini, L; Bettati, S; Bobbio, A; Caporale, D; Carbognani, P; Internullo, E; Rossini, E; Rusca, M | 1 |
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O | 1 |
Lam, KF; Lau, CP; Lee, WL; Siu, CW; Tse, HF | 1 |
González Oliva, JC; Pou Potau, M; Ramírez de Arellano Serna, M; Salas Gama, KR; Saurina i Solé, A | 1 |
Globits, S; Hirschl, MM; Wollmann, C | 1 |
Becker, R; Katus, HA; Li, J; Zitron, E | 1 |
Cole, JB; Engebretsen, KM; Fritzlar, SJ; Holger, JS; Stellpflug, SJ | 1 |
Shen, SL; Zhao, YC | 1 |
Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
Belardinelli, L; Machado, AD; Nearing, BD; Sobrado, LF; Varone, BB; Verrier, RL; Zeng, D | 1 |
Celi, LA; Chahin, A; Chen, KP; Cooper, AZ; Ghassemi, MM; Moskowitz, A | 1 |
Duan, X; Gui, Y; Jia, J; Li, S; Liu, CC; Liu, G; Lu, Y; Zhang, M | 1 |
Blackwood, B; Chean, CS; Duarte, R; Hill, R; Johnston, BW; McAuley, DF; Welters, ID | 1 |
Ainsworth, M; Bookstaver, D; Gleaton, M; Milner, E | 1 |
Bando, Y; Ishii, H; Otori, K; Yokota, N | 1 |
Ainsworth, M; Bookstaver, DA; Gleaton, M; Milner, E | 1 |
15 review(s) available for amiodarone and diltiazem
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half-Life; Humans; Hypertension; Lidocaine; Metoprolol; Nadolol; Nifedipine; Propanolamines; Propranolol; Tocainide; Verapamil | 1983 |
[Treatment of coronary arterial spasm].
Topics: Amiodarone; Coronary Vasospasm; Denervation; Diltiazem; Humans; Isosorbide Dinitrate; Myocardial Revascularization; Nifedipine; Nitroglycerin; Phenoxybenzamine; Phentolamine; Reserpine; Verapamil | 1982 |
[Drug therapy of atrial fibrillation: control of heart rate versus establishing sinus rhythm].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Diltiazem; Electric Countershock; Electrocardiography; Heart Rate; Humans; Survival Rate; Treatment Outcome | 1996 |
Systematic review of the management of atrial fibrillation in patients with heart failure.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Digoxin; Diltiazem; Electric Countershock; Heart Failure; Humans; Retrospective Studies | 2000 |
Atrial fibrillation: is rate stabilization a valid clinical strategy?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Protocols; Diltiazem; Heart Rate; Humans; Morbidity; Patient Selection; Risk Factors; Treatment Outcome | 2001 |
Risks and benefits of rate control versus maintenance of sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Clinical Trials as Topic; Diltiazem; Heart Conduction System; Heart Rate; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Stroke; Therapeutic Equivalency | 2003 |
Pharmacological rate control of atrial fibrillation.
Topics: Amiodarone; Atenolol; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diltiazem; Heart Rate; Humans; Metoprolol; Randomized Controlled Trials as Topic; Verapamil | 2004 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Humans; Timolol; Verapamil | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Timolol; Verapamil | 2003 |
Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Coronary Artery Bypass; Digoxin; Diltiazem; Drug Therapy, Combination; Electric Countershock; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Length of Stay; Male; Middle Aged; Postoperative Complications; Procainamide; Retrospective Studies; Treatment Outcome | 2005 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2004 |
Atrial fibrillation (recent onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2005 |
Management of new onset atrial fibrillation in critically unwell adult patients: a systematic review and narrative synthesis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diltiazem; Electric Countershock; Humans; Magnesium | 2022 |
10 trial(s) available for amiodarone and diltiazem
Article | Year |
---|---|
Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Electric Countershock; Female; Germany; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Research Design | 1997 |
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Electric Countershock; Female; Humans; Male; Middle Aged; Premedication; Recurrence; Single-Blind Method; Treatment Outcome | 2000 |
Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diltiazem; Electric Countershock; Follow-Up Studies; Heart Rate; Hospitalization; Humans; Middle Aged; Physical Exertion; Quality of Life | 2000 |
Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; APACHE; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Chi-Square Distribution; Critical Illness; Diltiazem; Female; Heart Rate; Humans; Intensive Care Units; Male; Prospective Studies; Treatment Outcome | 2001 |
Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Calcium Channels, L-Type; Chronic Disease; Diltiazem; Electric Countershock; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Prospective Studies; Secondary Prevention | 2003 |
Diltiazem versus amiodarone to prevent atrial fibrillation in coronary surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Extracorporeal Circulation; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Ventricular Fibrillation | 2005 |
Postoperative outcome of patients undergoing lung resection presenting with new-onset atrial fibrillation managed by amiodarone or diltiazem.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diltiazem; Female; Humans; Male; Middle Aged; Pneumonectomy; Postoperative Care; Prospective Studies; Recurrence; Treatment Outcome | 2007 |
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Diltiazem; Female; Humans; Incidence; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Single-Blind Method; Sotalol; Treatment Outcome; Turkey | 2008 |
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Digoxin; Diltiazem; Female; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Tachycardia, Ventricular; Treatment Outcome | 2009 |
[A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anesthesia; Atrial Fibrillation; Child; Diltiazem; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Treatment Outcome; Young Adult | 2010 |
57 other study(ies) available for amiodarone and diltiazem
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Fluoresceins; Fluorescent Dyes; Humans; Models, Molecular; Multivariate Analysis; Permeability; Quantitative Structure-Activity Relationship | 2005 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results | 2006 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Use of drugs in cardiac rehabilitation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Diltiazem; Drug Therapy, Combination; Electrocardiography; Exercise Test; Heart Diseases; Humans; Middle Aged; Nifedipine; Nitrates; Nitroglycerin; Physical Exertion; Verapamil | 1986 |
Compared efficacy of quinidine, amiodarone and diltiazem on both nomotopic and ectopic automaticity in the rat heart.
Topics: Amiodarone; Animals; Atrial Function; Diltiazem; Female; Heart Atria; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Quinidine; Rats; Rats, Inbred Strains; Ventricular Function | 1987 |
Malignant course of a benign anomaly: myocardial bridging.
Topics: Adult; Amiodarone; Cardiomyopathies; Coronary Angiography; Diltiazem; Electrocardiography; Electrophysiology; Humans; Male; Syncope; Tachycardia | 1987 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem; Lidocaine; Mexiletine; Nifedipine; Phenoxybenzamine; Prazosin; Propafenone; Propiophenones; Propranolol; Stellate Ganglion; Verapamil | 1986 |
An open comparison of amiodarone with diltiazem and glyceryl trinitrate in patients with stable exertional angina.
Topics: Aged; Amiodarone; Angina Pectoris; Benzazepines; Benzofurans; Diltiazem; Electrocardiography; Female; Humans; Male; Middle Aged; Nitroglycerin; Physical Exertion | 1985 |
Sinus arrest and hypotension with combined amiodarone-diltiazem therapy.
Topics: Amiodarone; Benzazepines; Benzofurans; Diltiazem; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypotension; Middle Aged; Myocardial Contraction; Sinoatrial Node | 1985 |
[Strategy of the treatment of vasospastic angina pectoris].
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Arteriosclerosis; Coronary Artery Bypass; Coronary Vasospasm; Diltiazem; Humans; Middle Aged; Nifedipine; Nitroglycerin; Radiography; Verapamil | 1983 |
[Treatment of unstable angina pectoris with combined amiodarone-diltiazem].
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Benzazepines; Benzofurans; Diltiazem; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged | 1982 |
Comparison of the frequency-dependent effects on the atrioventricular node of verapamil, amiodarone, digoxin, and diltiazem in isolated guinea pig hearts.
Topics: Amiodarone; Animals; Atrioventricular Node; Cardiac Pacing, Artificial; Computer Simulation; Digoxin; Diltiazem; Electric Stimulation; Electrocardiography; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Verapamil | 1995 |
Retinal maculopathy possibly associated with amiodarone medication.
Topics: Amiodarone; Diltiazem; Female; Fundus Oculi; Humans; Laser Therapy; Middle Aged; Retina; Retinal Diseases; Tachycardia, Paroxysmal; Triazolam; Visual Acuity | 1994 |
How to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Digoxin; Diltiazem; Electrocardiography; Female; Fourier Analysis; Guinea Pigs; Heart Rate; Male; Signal Processing, Computer-Assisted; Verapamil | 1996 |
Modifications in the evolution of the dominant frequency in ventricular fibrillation induced by amiodarone, diltiazem, and flecainide. An experimental study.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; Dogs; Electrocardiography; Flecainide; Fourier Analysis; Signal Processing, Computer-Assisted; Time Factors; Ventricular Fibrillation | 1996 |
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Topics: Adenosine Triphosphatases; Amiodarone; Amitriptyline; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Colchicine; Cricetinae; Cyclosporine; Daunorubicin; Diltiazem; Kinetics; Micelles; Progesterone; Propranolol; Structure-Activity Relationship; Verapamil; Vinblastine | 2000 |
Atrial fibrillation control and cardioversion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diltiazem; Electric Countershock; Humans; Treatment Outcome | 2001 |
Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diltiazem; Heart Rate; Humans; Randomized Controlled Trials as Topic; Vasodilator Agents | 2001 |
Effect of amiodarone +/- diltiazem +/- beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Critical Pathways; Diltiazem; Drug Therapy, Combination; Female; Hospital Costs; Humans; Incidence; Length of Stay; Male; Middle Aged; Outcome Assessment, Health Care; Postoperative Period; Preoperative Care; Vasodilator Agents | 2002 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Diltiazem; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Heart Block; Humans; Male; Middle Aged; Nitrates; Nitroglycerin; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Spasm; Time Factors; Vasodilator Agents; Ventricular Fibrillation | 2002 |
[Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Chronic Disease; Diltiazem; Electric Countershock; Female; Humans; Male; Middle Aged; Treatment Outcome | 2002 |
Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Diltiazem; Electric Countershock; Humans; Randomized Controlled Trials as Topic | 2003 |
High-throughput screening for the assessment of time-dependent inhibitions of new drug candidates on recombinant CYP2D6 and CYP3A4 using a single concentration method.
Topics: Amiodarone; Animals; Baculoviridae; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Enzyme Inhibitors; Fluorescence; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Midazolam; Propafenone; Quinolines; Recombinant Proteins; Troleandomycin; Verapamil | 2004 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium Channel Blockers; Cardiovascular Agents; Combined Modality Therapy; Digoxin; Diltiazem; Female; Humans; Hypothyroidism; Kidney Failure, Chronic; Myocardial Infarction; Pacemaker, Artificial; Renal Dialysis | 2010 |
A 2-year survey of treatment of acute atrial fibrillation in an ED.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Emergency Service, Hospital; Female; Flecainide; Humans; Male; Middle Aged; Sulfonamides; Time Factors; Treatment Outcome | 2011 |
PMS: premenstrual storm? An unusual cause of electrical storm in a young woman with vasospastic angina.
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Biomarkers; Defibrillators, Implantable; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Heart Arrest; Humans; Lorazepam; Natriuretic Peptide, Brain; Pentaerythritol Tetranitrate; Peptide Fragments; Premenstrual Syndrome; Tachycardia, Ventricular; Troponin T; Vasodilator Agents | 2011 |
Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Cardiotoxins; Diltiazem; Dose-Response Relationship, Drug; Drug Overdose; Drug Therapy, Combination; Fat Emulsions, Intravenous; Female; Humans; Hypoglycemic Agents; Insulin; Metoprolol; Suicide, Attempted; Treatment Outcome | 2011 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |
Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect.
Topics: Amiodarone; Analysis of Variance; Animals; Arterial Pressure; Benzazepines; Blood Pressure; Bradycardia; Diltiazem; Dronedarone; Isoproterenol; Ivabradine; Myocardial Contraction; Swine | 2013 |
Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data.
Topics: Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Critical Care; Databases, Factual; Diltiazem; Disease-Free Survival; Electronic Health Records; Female; Humans; Male; Metoprolol; Middle Aged; Survival Rate | 2017 |
Direct analysis in real time-mass spectrometry for rapid quantification of five anti-arrhythmic drugs in human serum: application to therapeutic drug monitoring.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Computer Systems; Diltiazem; Drug Monitoring; Humans; Metoprolol; Pharmaceutical Preparations; Propafenone; Tandem Mass Spectrometry; Verapamil | 2020 |
Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
Topics: Adult; Aged; Amiodarone; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrazoles; Pyridones; Rosuvastatin Calcium; Simvastatin | 2022 |
[Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir].
Topics: Adenosine Monophosphate; Alanine; Amiodarone; Anticoagulants; Atorvastatin; Bisoprolol; COVID-19 Drug Treatment; Dexamethasone; Diltiazem; Drug Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Warfarin | 2022 |
A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations.
Topics: Amiodarone; Cohort Studies; Diltiazem; Humans; Pyridones | 2023 |